Hoth Therapeutics Inc., a biopharmaceutical company committed to developing innovative therapies for unmet medical needs, has collaborated with OnTargetx R&D Inc. to accelerate research for its cancer ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs, today announced its collaboration with OnTargetx R&D Inc. to ...

Sorafenib is an oral multikinase inhibitor that inhibits tumor growth and proliferation by interfering with several receptor tyrosine ... Flt3, c-KIT and the RAF kinase and MAPK pathways.

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...

During a Case-Based Roundtable® event, Nitin Jain, MD, and participants discussed treating a patient with CLL after ...

Meal kits and prepared meal delivery have changed weekday dinners for good. You don't have to run to the grocery store last minute or deal with the stress of figuring out what to make after a long ...

Life Kit is here to help you get it together. Want another life hack? Try Life Kit+. You'll support the show and unlock exclusive curated playlists and sponsor-free listening. Learn more at plus ...

February 13, 2025 • Plus: how to deal with an awful brother-in-law, what to do with a box of mementos you shared with your ex and how to tell a bestie you don't want to go on a couples trip ...

Here this group conducts a single-arm, open-label, phase II trial assessing the combination therapy of regorafenib (tyrosine kinase inhibitor) and sintilimab (PD-1 targeting) as a safe and ...

Neurodegeneration refers to the progressive atrophy and loss of function of neurons, which is present in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease ...